Protective role of pigment epithelium‐derived factor (PEDF) in early phase of experimental diabetic retinopathy
暂无分享,去创建一个
Takanori Matsui | Yumiko Yoshida | T. Imaizumi | S. Yamagishi | T. Matsui | Y. Yoshida | K. Fukami | R. Yamakawa | Tsutomu Imaizumi | Sho-Ichi Yamagishi | Yuko Jinnouchi | Kei Fukami | Ryoji Yamakawa | Y. Jinnouchi
[1] T. Imaizumi,et al. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF , 2005, Cell and Tissue Research.
[2] S. Yamagishi,et al. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation , 2003, Diabetologia.
[3] T. Imaizumi,et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. , 2006, The Journal of clinical endocrinology and metabolism.
[4] T. Imaizumi,et al. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. , 2005, Current pharmaceutical design.
[5] T. Imaizumi,et al. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice , 2007, Brain Research.
[6] Z. Makita,et al. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. , 2002, Biochemical and biophysical research communications.
[7] S. Yamagishi,et al. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] K. Ohgami,et al. Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation , 2007, British Journal of Ophthalmology.
[9] Takafumi Yoshida,et al. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. , 2007, The American journal of pathology.
[10] I. Perlman,et al. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. , 2002, Experimental eye research.
[11] H. Kaneto,et al. Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy. , 2008, Diabetes research and clinical practice.
[12] K. Yamashita,et al. Electroretinography using contact lens electrode with built-in light source in dogs. , 2005, The Journal of veterinary medical science.
[13] M. Bartoli,et al. Role of NADPH oxidase in retinal vascular inflammation. , 2008, Investigative ophthalmology & visual science.
[14] T. Imaizumi,et al. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. , 2006, Microvascular research.
[15] J. Sahel,et al. Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants , 2005, British Journal of Ophthalmology.
[16] A. Yoshimura,et al. Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation , 2004 .
[17] A. Yoshimura,et al. Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression* , 2006, Journal of Biological Chemistry.
[18] F. Bosch-Morell,et al. Early lipoic acid intake protects retina of diabetic mice , 2008, Free radical research.
[19] T. Imaizumi,et al. Pigment epithelium-derived factor (PEDF) prevents advanced glycation end products (AGEs)-elicited endothelial nitric oxide synthase (eNOS) reduction through its anti-oxidative properties. , 2007, Protein and peptide letters.
[20] T. Gardner,et al. Insulin Rescues Retinal Neurons from Apoptosis by a Phosphatidylinositol 3-Kinase/Akt-mediated Mechanism That Reduces the Activation of Caspase-3* , 2001, The Journal of Biological Chemistry.
[21] Takafumi Yoshida,et al. Pigment-Epithelium-Derived Factor Suppresses Expression of Receptor for Advanced Glycation End Products in the Eye of Diabetic Rats , 2007, Ophthalmic Research.
[22] C. Barnstable,et al. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential , 2004, Progress in Retinal and Eye Research.
[23] M. Bartoli,et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. , 2005, Current drug targets.
[24] G. Lang,et al. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy , 2003, Diabetologia.
[25] Y. Khalifa,et al. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. , 2005, The American journal of pathology.
[26] J. Tombran-Tink,et al. Pigment epithelium‐derived factor protects cultured retinal neurons against hydrogen peroxide‐induced cell death , 1999, Journal of neuroscience research.
[27] D. Sorescu,et al. NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.